Systemic lupus erythematosus (SLE) is a complex autoimmune disease with significant
clinical heterogeneity. Recent advances in our understanding of the genetic, molecular, and …

Objective To formulate consensus treatment plans (CTPs) for induction therapy of newly
diagnosed proliferative lupus nephritis (LN) in juvenile systemic lupus erythematosus (SLE). …

Objective To provide evidence‐based recommendations and expert guidance for the
management of Kawasaki disease (KD), focusing on clinical scenarios more commonly addressed …

Background Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA)
syndrome is the most common periodic fever syndrome in children. There is considerable …

In order to describe the incidence and characteristics of major infections in juvenile-onset
systemic lupus erythematosus (jSLE), we studied a cohort of 120 patients (51% Hispanic and …

Lymphedema‐distichiasis (LD) syndrome is a clinically variable autosomal dominant disorder.
The disorder is caused by mutations in the forkhead transcription factor FOXC2 gene on …

Healthcare providers were rapidly forced to modify the way they practiced medicine during
the coronavirus disease 2019 (COVID-19) pandemic. Many providers transitioned from …

BACKGROUND: Childhood-onset systemic lupus erythematosus (c-SLE) is a complex
autoimmune disease that requires systemic immunosuppressive therapy. Infections are the …

Objectives To describe the selection, development and implementation of quality measures (QMs)
for juvenile idiopathic arthritis (JIA) by the Pediatric Rheumatology Care and …

Despite advancements in the conduct and dissemination of scientific research, there remains
a shocking 17-year lag in the time it takes to translate evidence into clinical practice, and …